Biopharma company Lexicon Pharmaceuticals, Inc. has announced positive topline results from its Phase 1a study of LX9211...
Bridge Biotherapeutics Inc., a clinical stage biotech company headquartered in Seongnam, South Korea, has signed a licen...
Singapore – China's National Medical Products Administration approves FibroGen's roxadustat, a hypoxia-i...
UK-based Avacta Group plc , the developer of Affimer biotherapeutics and reagents and Korea's LG Chem Life Science...
Innovent Biologics, Inc. (Innovent), a world-class China-based biopharmaceutical company that develops and commerci...
Multiple myeloma patients from Australia will have world-first access to a new first-in-class drug developed to treat th...
TauRx, a leader in neurodegenerative disease research, announced that the US Food and Drug Administration (FDA) has gran...
Diamyd Medical is dedicated to finding a cure for diabetes and other serious inflammatory diseases through pharmaceutica...
Takeda Pharmaceutical Company Limited announced that the European Commission (EC) granted marketing authorization for AL...
HitGen Ltd has announced that the company has entered into a drug discovery research collaboration with Biogen to identi...
Singapore – Novartis announced that the Health Sciences Authority (HSA) has approved Aimovig (erenumab) ...
OBI Pharma, Inc., a Taiwan biopharma company, has announced that the U.S. Food and Drug Administration (FDA) h...
Singapore - Exscientia, the company leading the use of Artificial Intelligence (AI) in drug discovery, announces that is...
MEI Pharma, Inc. and Kyowa Hakko Kirin Co., Ltd. (KHK), have announced the execution of a license agreement granting KHK...
Singapore – The Janssen Pharmaceutical Companies of Johnson & Johnson announced that the U.S. Food and D...
Singapore – Halozyme has out-licensed its ENHANZE drug delivery technology to Roche for the exclusi...
Singapore – A non-opioid drug developed by Pfizer and Eli Lilly met the main go...
Singapore - The FDA approves Regeneron Pharmaceuticals and development partner Sanofi's DUPIXENT (dupilumab) a...
